Harborne Steven P D, Ruprecht Jonathan J, Kunji Edmund R S
The Medical Research Council, Mitochondrial Biology Unit, Cambridge Biomedical Campus, Wellcome Trust/MRC Building, Hills Road, Cambridge CB2 0XY, UK.
The Medical Research Council, Mitochondrial Biology Unit, Cambridge Biomedical Campus, Wellcome Trust/MRC Building, Hills Road, Cambridge CB2 0XY, UK.
Biochim Biophys Acta. 2015 Oct;1847(10):1245-53. doi: 10.1016/j.bbabio.2015.07.002. Epub 2015 Jul 9.
The mitochondrial ATP-Mg/Pi carrier imports adenine nucleotides from the cytosol into the mitochondrial matrix and exports phosphate. The carrier is regulated by the concentration of cytosolic calcium, altering the size of the adenine nucleotide pool in the mitochondrial matrix in response to energetic demands. The protein consists of three domains; (i) the N-terminal regulatory domain, which is formed of two pairs of fused calcium-binding EF-hands, (ii) the C-terminal mitochondrial carrier domain, which is involved in transport, and (iii) a linker region with an amphipathic α-helix of unknown function. The mechanism by which calcium binding to the regulatory domain modulates substrate transport in the carrier domain has not been resolved. Here, we present two new crystal structures of the regulatory domain of the human isoform 1. Careful analysis by SEC confirmed that although the regulatory domain crystallised as dimers, full-length ATP-Mg/Pi carrier is monomeric. Therefore, the ATP-Mg/Pi carrier must have a different mechanism of calcium regulation than the architecturally related aspartate/glutamate carrier, which is dimeric. The structure showed that an amphipathic α-helix is bound to the regulatory domain in a hydrophobic cleft of EF-hand 3/4. Detailed bioinformatics analyses of different EF-hand states indicate that upon release of calcium, EF-hands close, meaning that the regulatory domain would release the amphipathic α-helix. We propose a mechanism for ATP-Mg/Pi carriers in which the amphipathic α-helix becomes mobile upon release of calcium and could block the transport of substrates across the mitochondrial inner membrane.
线粒体ATP-Mg/Pi载体将腺嘌呤核苷酸从细胞质溶胶导入线粒体基质,并输出磷酸根。该载体受细胞质钙浓度的调节,根据能量需求改变线粒体基质中腺嘌呤核苷酸池的大小。该蛋白质由三个结构域组成:(i)N端调节结构域,由两对融合的钙结合EF手结构组成;(ii)C端线粒体载体结构域,参与转运;(iii)一个连接区域,带有一个功能未知的两亲性α螺旋。钙与调节结构域结合从而调节载体结构域中底物转运的机制尚未明确。在此,我们展示了人类异构体1调节结构域的两个新晶体结构。通过尺寸排阻色谱法进行的仔细分析证实,尽管调节结构域结晶为二聚体,但全长ATP-Mg/Pi载体是单体。因此,ATP-Mg/Pi载体的钙调节机制必定与结构相关的天冬氨酸/谷氨酸载体不同,后者是二聚体。结构显示,一个两亲性α螺旋在EF手3/4的疏水裂隙中与调节结构域结合。对不同EF手状态的详细生物信息学分析表明,钙释放后,EF手关闭,这意味着调节结构域会释放两亲性α螺旋。我们提出了一种ATP-Mg/Pi载体的机制,即两亲性α螺旋在钙释放后变得可移动,并可能阻断底物穿过线粒体内膜的转运。